A Phase II Controlled Trial of Allogenic Mesenchymal Stem Cells for the Treatment

Project: Research project

Description

Northwestern University will be a clinical site for a planned clinical trial and will enroll 13 participants in the trial by interacting with the trial PI and co-investigators and complete all CRFs, comply with data management and analysis plans for the trial and also complete site specific tasks such as the local IRB and research unit applications, budget and clean cell facility utilization.
StatusActive
Effective start/end date10/1/179/30/22

Funding

  • Medical University Of South Carolina (MUSC18-126-8D365//Award Letter 10/1/17)
  • Lupus Foundation of America, Inc. (MUSC18-126-8D365//Award Letter 10/1/17)

Fingerprint

Research Ethics Committees
Budgets
Mesenchymal Stromal Cells
Research Personnel
Clinical Trials
Research